|Bid||30.49 x 1000|
|Ask||31.56 x 1400|
|Day's Range||30.17 - 31.74|
|52 Week Range||16.87 - 61.59|
|Beta (5Y Monthly)||1.97|
|PE Ratio (TTM)||N/A|
|Earnings Date||May 04, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||42.86|
In the latest trading session, Invitae (NVTA) closed at $31.22, marking a -0.22% move from the previous day.
Invitae (NYSE: NVTA), a leading medical genetics company, today announced the appointment of Roxi Wen as its chief financial officer, effective June 21, 2021. Wen brings decades of success as a senior financial executive where she scaled global technology and medical technology companies.
What happened Shares of Invitae (NYSE: NVTA) fell 17.5% in May, according to data provided by S&P Global Market Intelligence. Investors were not impressed with the company's first-quarter earnings early in the month, especially management's inability to control costs.